Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Arlene A. McLean"'
Publikováno v:
Journal of Infection. 1:73-88
Summary It has been shown that polyvalent pneumococcal polysaccharide vaccine, now commercially available, is safe, antigenic, and provides protection against pneumonias caused by the pneumococcal serotypes which are present in the vaccine. Early stu
Autor:
Buynak Eb, Robert E. Weibel, William J. McAleer, Victor M. Villarejos, Maurice R. Hilleman, Henry Z. Markus, Arlene A. McLean
Publikováno v:
Journal of Biological Standardization. 10:329-333
A single-dose, low-cost vaccine delivery system (Ezeject®) consisting of lyophilized measles (Moraten—Attenuvax®) vaccine loaded into a pre-filled single-dose plastic syringe with a squeezable body portion has been developed in these laboratories
Publikováno v:
Experimental Biology and Medicine. 165:260-263
Antibody persistence was measured in children in the open community 10.5 years after combined measles-mumps-rubella (14 children), 9 years after measles-rubella (17 children), 10.5 years after mumps-rubella (9 children), and 7 years after measles-mum
Publikováno v:
Pediatrics. 61:5-11
Hemagglutination-inhibiting antibodies were retained in comparable levels eight years after vaccination with Enders' original Edmonston and more attenuated Moraten (Attenuvax) and Schwarz line measles vaccines. Neutralizing antibody persisted without
Autor:
Wallace L. Davidson, A. F. Woodhour, Arlene A. McLean, Maurice R. Hilleman, Philip P. Vella, Robert E. Weibel
Publikováno v:
Experimental Biology and Medicine. 156:144-150
SummaryClinical studies of 12- and 14-valent pneumococcal capsular polysaccha-ride vaccines were carried out among 76 adults and 42 children. All but a small proportion of persons developed significant increases in homologous antibody against all cap
Publikováno v:
Pediatrics. 56:380-387
Antibody in human subjects persisted without substantial decline for 8 years after mumps vaccine (Jeryl Lynn), for 6 years after measles (Attenuvax), for 5½ years after rubella vaccine (HPV-77 duck), for 5 years after measles-mumps-rubella and mumps
Autor:
Eugene B. Buynak, Arlene A. McLean, William J. McAleer, Robert E. Weibel, D. Eugene Wampler, Maurice R. Hilleman, Henry Z. Markus, William J. Miller
Publikováno v:
Experimental Biology and Medicine. 175:314-319
Vaccine against human hepatitis B was prepared using antigen derived from hepatitis B carrier hepatoma cells grown in the interstices of a Diaflo hollow filter unit. Hepatitis B surface antigen (HBsAg) produced by these cells was purified by immune a
Publikováno v:
Journal of Biological Standardization. 8:281-287
Dried live measles, mumps and rubella virus vaccines prepared in a new stabilizing medium were tested for loss of potency, according to time, at a range of temperatures from −20°C to 54–56°C. All vaccines proved remarkably stable and predictive
Autor:
Arlene A. McLean, A. F. Woodhour, Maurice R. Hilleman, Philip P. Vella, Robert E. Weibel, Victor M. Villarejos
Publikováno v:
Experimental Biology and Medicine. 153:436-440
SummaryPurified group A and C me-ningococcal polysaccharide vaccines prepared in these laboratories caused remarkably little local or systemic reaction and were highly effective in stimulating serum bactericidal antibody in studies carried out in adu
Autor:
Maurice R. Hilleman, Victor M. Villarejos, Alfred J. Carlson, Arlene A. McLean, Robert E. Weibel, Eugene B. Buynak
Publikováno v:
Experimental Biology and Medicine. 165:323-326
Eleven lots of combined bivalent and trivalent vaccines containing the measles (Moraten), mumps (Jeryl Lynn), and rubella (RA 2713) viruses gave satisfactory results in tests in initially seronegative children (measles, 493 children; mumps, 377; rube